THE COMPLEXED PSA ASSAY FOR THE BAYER IMMUNO 1 SYSTEM

Prostate-specific Antigen (psa) For Management Of Prostate Cancers

BAYER CORP.

The following data is part of a premarket notification filed by Bayer Corp. with the FDA for The Complexed Psa Assay For The Bayer Immuno 1 System.

Pre-market Notification Details

Device IDK980376
510k NumberK980376
Device Name:THE COMPLEXED PSA ASSAY FOR THE BAYER IMMUNO 1 SYSTEM
ClassificationProstate-specific Antigen (psa) For Management Of Prostate Cancers
Applicant BAYER CORP. 511 BENEDICT AVE. Tarrytown,  NY  10591 -5097
ContactGabriel J Muraca, Jr.
CorrespondentGabriel J Muraca, Jr.
BAYER CORP. 511 BENEDICT AVE. Tarrytown,  NY  10591 -5097
Product CodeLTJ  
CFR Regulation Number866.6010 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1998-01-30
Decision Date1998-04-23
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.